Genetic Vulnerability and Susceptibility to Substance Dependence

Neuron

Volumn 69, Issue 4, 2011, Pages 618-627

  Bierut, Laura Jean ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ASPARAGINE; ASPARTIC ACID; CYTOCHROME P450 2A6; DOPAMINE 2 RECEPTOR; MU OPIATE RECEPTOR; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR ALPHA6; NICOTINIC RECEPTOR BETA3; NICOTINIC RECEPTOR BETA4; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALCOHOLISM; AMINO ACID SUBSTITUTION; ASIAN; CAUCASIAN; CHROMOSOME 15Q; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DRUG DEPENDENCE; ESOPHAGUS CANCER; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; LUNG CANCER; PHARMACOGENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TWINS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 79951694140     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.02.015     Document Type: Review

References (74)

1. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association (APA), American Psychiatric Association, Washington, DC. Fourth Edition.
2. Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., Dong Q., Zhang Q., Gu X., Vijayakrishnan J., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 2008, 40:616-622.
3. Amos C.I., Gorlov I.P., Dong Q., Wu X., Zhang H., Lu E.Y., Scheet P., Greisinger A.J., Mills G.B., Spitz M.R. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: A case-control study. J. Natl. Cancer Inst. 2010, 102:1199-1205.
4. Arias A., Feinn R., Kranzler H.R. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: A meta-analysis. Drug Alcohol Depend. 2006, 83:262-268.
5. Audrain-McGovern J., Al Koudsi N., Rodriguez D., Wileyto E.P., Shields P.G., Tyndale R.F. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 2007, 119:e264-e274.
6. Bierut L.J., Dinwiddie S.H., Begleiter H., Crowe R.R., Hesselbrock V., Nurnberger J.I., Porjesz B., Schuckit M.A., Reich T. Familial transmission of substance dependence: Alcohol, marijuana, cocaine, and habitual smoking: A report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry 1998, 55:982-988.
7. Bierut L.J., Stitzel J.A., Wang J.C., Hinrichs A.L., Grucza R.A., Xuei X., Saccone N.L., Saccone S.F., Bertelsen S., Fox L., et al. Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry 2008, 165:1163-1171.
8. Bierut L.J., Agrawal A., Bucholz K.K., Doheny K.F., Laurie C., Pugh E., Fisher S., Fox L., Howells W., Bertelsen S., et al. A genome-wide association study of alcohol dependence. Proc. Natl. Acad. Sci. USA 2010, 107:5082-5087.
9. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 2008, 40:695-701.
10. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc. Natl. Acad. Sci. USA 1998, 95:9608-9613.
11. Bowen C.A., Grant K.A. Pharmacological analysis of the heterogeneous discriminative stimulus effects of ethanol in rats using a three-choice ethanol-dizocilpine-water discrimination. Psychopharmacology (Berl.) 1998, 139:86-94.
12. Broderick P., Wang Y., Vijayakrishnan J., Matakidou A., Spitz M.R., Eisen T., Amos C.I., Houlston R.S. Deciphering the impact of common genetic variation on lung cancer risk: A genome-wide association study. Cancer Res. 2009, 69:6633-6641.
13. Current cigarette smoking among adults aged >18 years-United States, 2009. MMWR Morb. Mortal. Wkly. Rep. 2010, 59:1135-1140. Centers for Disease Control (CDC).
14. Chen X., Chen J., Williamson V.S., An S.S., Hettema J.M., Aggen S.H., Neale M.C., Kendler K.S. Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2009, 150B:926-933.
15. Edenberg H.J. The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res. Health 2007, 30:5-13.
16. Edenberg H.J., Koller D.L., Xuei X., Wetherill L., McClintick J.N., Almasy L., Bierut L.J., Bucholz K.K., Goate A., Aliev F., et al. Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol. Clin. Exp. Res. 2010, 34:840-852.
17. Enoch M.A. The role of GABA(A) receptors in the development of alcoholism. Pharmacol. Biochem. Behav. 2008, 90:95-104.
18. Falvella F.S., Galvan A., Colombo F., Frullanti E., Pastorino U., Dragani T.A. Promoter polymorphisms and transcript levels of nicotinic receptor CHRNA5. J. Natl. Cancer Inst. 2010, 102:1366-1370.
19. Fowler C.D., Lu Q., Johnson P.M., Marks M.J., Kenny P.J. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011, in press.
20. Frazer K.A., Murray S.S., Schork N.J., Topol E.J. Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 2009, 10:241-251.
21. Gelernter J., O'Malley S., Risch N., Kranzler H.R., Krystal J., Merikangas K., Kennedy J.L., Kidd K.K. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991, 266:1801-1807.
22. Goedde H.W., Agarwal D.P., Harada S. Genetic studies on alcohol-metabolizing enzymes: Detection of isozymes in human hair roots. Enzyme 1980, 25:281-286.
23. Grucza R.A., Wang J.C., Stitzel J.A., Hinrichs A.L., Saccone S.F., Saccone N.L., Bucholz K.K., Cloninger C.R., Neuman R.J., Budde J.P., et al. A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol. Psychiatry 2008, 64:922-929.
24. Harada S., Agarwal D.P., Goedde H.W., Tagaki S., Ishikawa B. Possible protective role against alcoholism for aldehyde dehydrogenase isozyme deficiency in Japan. Lancet 1982, 2:827.
25. Hashibe M., McKay J.D., Curado M.P., Oliveira J.C., Koifman S., Koifman R., Zaridze D., Shangina O., Wünsch-Filho V., Eluf-Neto J., et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat. Genet. 2008, 40:707-709.
26. Hasin D.S., Stinson F.S., Ogburn E., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2007, 64:830-842.
27. Heath A.C., Bucholz K.K., Madden P.A., Dinwiddie S.H., Slutske W.S., Bierut L.J., Statham D.J., Dunne M.P., Whitfield J.B., Martin N.G. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: Consistency of findings in women and men. Psychol. Med. 1997, 27:1381-1396.
28. Hindorff, L.A., Junkins, H.A., Hall, P.N., Mehta, J.P., and Manolio, T.A. (2010). A catalog of published genome-wide association studies. http://www.genome.gov/gwastudies.
29. Hong L.E., Hodgkinson C.A., Yang Y., Sampath H., Ross T.J., Buchholz B., Salmeron B.J., Srivastava V., Thaker G.K., Goldman D., Stein E.A. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc. Natl. Acad. Sci. USA 2010, 107:13509-13514.
30. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., Mukeria A., Szeszenia-Dabrowska N., Lissowska J., Rudnai P., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452:633-637.
31. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
32. Kendler K.S., Prescott C.A., Myers J., Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 2003, 60:929-937.
33. Krystal J.H., Staley J., Mason G., Petrakis I.L., Kaufman J., Harris R.A., Gelernter J., Lappalainen J. Gamma-aminobutyric acid type A receptors and alcoholism: Intoxication, dependence, vulnerability, and treatment. Arch. Gen. Psychiatry 2006, 63:957-968.
34. Kuryatov A., Berrettini W., Lindstrom J. Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)2α5 AChR function. Mol. Pharmacol. 2011, 79:119-125.
35. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: A comprehensive review. Behav. Pharmacol. 2009, 20:1-17.
36. Le Marchand L., Derby K.S., Murphy S.E., Hecht S.S., Hatsukami D., Carmella S.G., Tiirikainen M., Wang H. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res. 2008, 68:9137-9140.
37. Li M.D. The genetics of nicotine dependence. Curr. Psychiatry Rep. 2006, 8:158-164.
38. Lips E.H., Gaborieau V., McKay J.D., Chabrier A., Hung R.J., Boffetta P., Hashibe M., Zaridze D., Szeszenia-Dabrowska N., Lissowska J., et al. Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. Int. J. Epidemiol. 2010, 39:563-577.
39. Liu P., Vikis H.G., Wang D., Lu Y., Wang Y., Schwartz A.G., Pinney S.M., Yang P., de Andrade M., Petersen G.M., et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J. Natl. Cancer Inst. 2008, 100:1326-1330.
40. Liu J.Z., Tozzi F., Waterworth D.M., Pillai S.G., Muglia P., Middleton L., Berrettini W., Knouff C.W., Yuan X., Waeber G., et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 2010, 42:436-440.
41. Macgregor S., Lind P.A., Bucholz K.K., Hansell N.K., Madden P.A., Richter M.M., Montgomery G.W., Martin N.G., Heath A.C., Whitfield J.B. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: An integrated analysis. Hum. Mol. Genet. 2009, 18:580-593.
42. Malaiyandi V., Goodz S.D., Sellers E.M., Tyndale R.F. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1812-1819.
43. Merikangas K.R., Stolar M., Stevens D.E., Goulet J., Preisig M.A., Fenton B., Zhang H., O'Malley S.S., Rounsaville B.J. Familial transmission of substance use disorders. Arch. Gen. Psychiatry 1998, 55:973-979.
44. Minematsu N., Nakamura H., Furuuchi M., Nakajima T., Takahashi S., Tateno H., Ishizaka A. Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms. Eur. Respir. J. 2006, 27:289-292.
45. Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 2004, 291:1238-1245.
46. Oscarson M., McLellan R.A., Gullstén H., Agúndez J.A., Benítez J., Rautio A., Raunio H., Pelkonen O., Ingelman-Sundberg M. Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism. FEBS Lett. 1999, 460:321-327.
47. Oscarson M., McLellan R.A., Asp V., Ledesma M., Bernal Ruiz M.L., Sinues B., Rautio A., Ingelman-Sundberg M. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity. Hum. Mutat. 2002, 20:275-283.
48. Parsian A., Todd R.D., Devor E.J., O'Malley K.L., Suarez B.K., Reich T., Cloninger C.R. Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch. Gen. Psychiatry 1991, 48:655-663.
49. Pillai S.G., Ge D., Zhu G., Kong X., Shianna K.V., Need A.C., Feng S., Hersh C.P., Bakke P., Gulsvik A., et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet. 2009, 5:e1000421.
50. Saccone N.L., Wang J.C., Breslau N., Johnson E.O., Hatsukami D., Saccone S.F., Grucza R.A., Sun L., Duan W., Budde J., et al. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res. 2009, 69:6848-6856.
51. Saccone N.L., Culverhouse R.C., Schwantes-An T.H., Cannon D.S., Chen X., Cichon S., Giegling I., Han S., Han Y., Keskitalo-Vuokko K., et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: A meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 2010, 6:6.
52. Saccone N.L., Schwantes-An T.H., Wang J.C., Grucza R.A., Breslau N., Hatsukami D., Johnson E.O., Rice J.P., Goate A.M., Bierut L.J. Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. Genes Brain Behav. 2010, 9:741-750.
53. Schlaepfer I.R., Hoft N.R., Collins A.C., Corley R.P., Hewitt J.K., Hopfer C.J., Lessem J.M., McQueen M.B., Rhee S.H., Ehringer M.A. The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol. Psychiatry 2008, 63:1039-1046.
54. Schoedel K.A., Hoffmann E.B., Rao Y., Sellers E.M., Tyndale R.F. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004, 14:615-626.
55. Sherva R., Rice J.P., Neuman R.J., Rochberg N., Saccone N.L., Bierut L.J. Associations and interactions between SNPs in the alcohol metabolizing genes and alcoholism phenotypes in European Americans. Alcohol. Clin. Exp. Res. 2009, 33:848-857.
56. Sherva R., Kranzler H.R., Yu Y., Logue M.W., Poling J., Arias A.J., Anton R.F., Oslin D., Farrer L.A., Gelernter J. Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 2010, 35:1921-1931.
57. Shiraishi K., Kohno T., Kunitoh H., Watanabe S., Goto K., Nishiwaki Y., Shimada Y., Hirose H., Saito I., Kuchiba A., et al. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis 2009, 30:65-70.
58. Siontis K.C., Patsopoulos N.A., Ioannidis J.P. Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur. J. Hum. Genet. 2010, 18:832-837.
59. Smith R.M., Alachkar H., Papp A.C., Wang D., Mash D.C., Wang J.C., Bierut L.J., Sadee W. Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. Eur. J. Hum. Genet. 2011, 19:76-83.
60. Su T., Bao Z., Zhang Q.Y., Smith T.J., Hong J.Y., Ding X. Human cytochrome P450 CYP2A13: Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000, 60:5074-5079.
61. Suzdak P.D., Schwartz R.D., Skolnick P., Paul S.M. Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc. Natl. Acad. Sci. USA 1986, 83:4071-4075.
62. Tanaka F., Yamamoto K., Suzuki S., Inoue H., Tsurumaru M., Kajiyama Y., Kato H., Igaki H., Furuta K., Fujita H., et al. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut 2010, 59:1457-1464.
63. Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Budgets 2009, The National Center on Addiction and Substance Abuse at Columbia University, National Center on Addiction and Substance Abuse at Columbia University, New York.
64. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-642.
65. Thorgeirsson T.E., Gudbjartsson D.F., Surakka I., Vink J.M., Amin N., Geller F., Sulem P., Rafnar T., Esko T., Walter S., et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 2010, 42:448-453. ENGAGE Consortium.
66. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 2010, 42:441-447. Tobacco and Genetics (TAG) Consortium.
67. Treutlein J., Cichon S., Ridinger M., Wodarz N., Soyka M., Zill P., Maier W., Moessner R., Gaebel W., Dahmen N., et al. Genome-wide association study of alcohol dependence. Arch. Gen. Psychiatry 2009, 66:773-784.
68. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., True W., Lin N., Toomey R., Eaves L. Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry 1998, 55:967-972.
69. Vink J.M., Willemsen G., Boomsma D.I. Heritability of smoking initiation and nicotine dependence. Behav. Genet. 2005, 35:397-406.
70. Wang J.C., Cruchaga C., Saccone N.L., Bertelsen S., Liu P., Budde J.P., Duan W., Fox L., Grucza R.A., Kern J., et al. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum. Mol. Genet. 2009, 18:3125-3135.
71. Wolff P.H. Ethnic differences in alcohol sensitivity. Science 1972, 175:449-450.
72. Global Status Report on Alcohol 2004 2004, World Health Organization (WHO), World Health Organization, Geneva.
73. World Health Organization (WHO). (2010). Tobacco Key Facts. http://www.who.int/topics/tobacco/facts/en/index.html.
74. Yamazaki H., Inoue K., Hashimoto M., Shimada T. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch. Toxicol. 1999, 73:65-70.